Stryker (SYK) Long-Term Investments (2009 - 2010)

Stryker (SYK) reported Long-Term Investments of -$110.0 million for Q4 2010, down 170.06% year-over-year from $157.0 million in Q4 2009, and down 170.06% quarter-over-quarter from $157.0 million in Q4 2009.

Stryker (SYK) Long-Term Investments (2009 - 2010) Analysis & Trends

Stryker (SYK) has 2 years of Long-Term Investments data on file, last reported at -$110.0 million in Q4 2010.

  • Long-Term Investments for Q4 2010 came in at -$110.0 million, down 170.06% year-over-year; the trailing twelve-month figure through Dec 2010 was -$110.0 million (down 170.06% YoY), and the FY2010 annual result was -$110.0 million, down 170.06% from the prior year.
  • Long-Term Investments retreated to -$110.0 million in Q4 2010 per SYK's latest filing, from $157.0 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $157.0 million in Q4 2009 and troughed at -$110.0 million in Q4 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.09 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 285.60 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 166.25 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2010 -110.00 Mn
Dec 31, 2009 157.00 Mn